Lonza · 7 hours ago
Intern, Research & Development
Bend, OR
Internship
Onsite
InternLonza is a global leader in life sciences operating across five continents, and they are seeking interns for their Research & Development team. The role involves contributing to multidisciplinary teams and advancing technologies in the pharmaceutical industry.
BiotechnologyLife SciencePharmaceutical
Responsibilities
Designing and executing an individual project to be presented to the team at the end of the internship
Helping with the setup, execution and clean-up of laboratory experiments
Learn how to safely operate a range of instruments and equipment and demonstrates proficiency for achieving quality results
Apply knowledge of chemistry and material science fundamentals to assigned problem statements
Define problem statements using model-based hypotheses
Work independently and carry out assigned duties effectively
Other responsibilities as required
Qualification
Required
Must be currently pursuing an undergraduate or advanced degree in biology, chemistry, engineering, or a related life science with at least 40 university credits
Enthusiastic about the biopharmaceutical industry and learning about industry technology
Promote safety and demand high quality standards for work being performed
Established in mathematical and scientific principles
Demonstrate effective written and verbal communication skills, and be team-oriented
Company
Lonza
Lonza Group supplies products and services to pharmaceutical and agrochemical industries.
Founded in 1897
10001+ employees
H1B Sponsorship
Lonza has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (3)
2022 (1)
2021 (3)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$444.8M2023-11-06Post Ipo Debt· $444.8M
2020-12-07IPO
Leadership Team
Wolfgang Wienand
Chief Executive Officer
Alfons Ehinger
Founder
Recent News
NH Business Review
2026-01-17
Company data provided by crunchbase